Framework for laboratory harmonization of folate measurements in low- and middle-income countries and regions

被引:18
|
作者
Pfeiffer, Christine M. [1 ]
Zhang, Mindy [1 ]
Jabbar, Shameem [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Lab Sci, Natl Ctr Environm Hlth, 4770 Buford Hwy NE, Atlanta, GA 30341 USA
基金
比尔及梅琳达.盖茨基金会;
关键词
microbiologic assay; folic acid; 5-methyltetrahydrofolate; serum folate; red blood cell folate; cutoff value; WHOLE-BLOOD FOLATE; MICROBIOLOGICAL ASSAY; SPECIMEN STABILITY; US POPULATION; SERUM FOLATE; PLASMA;
D O I
10.1111/nyas.13532
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The measurement of serum and red blood cell folate, two commonly used biomarkers of folate status in populations, is complicated by analytical and data interpretation challenges. Folate results show poor comparability across laboratories, even using the same analytical technique. The folate microbiologic assay produces accurate results and requires simple instrumentation. Thus, it could be set up and maintained in low- and middle-income country laboratories. However, the assay has to be harmonized through the use of common critical reagents (e.g., microorganism and folate calibrator) in order to produce comparable results across laboratories and over time, so that the same cutoff values can be applied across surveys. There is a limited need for blood folate measurements in a country owing to the periodic nature of surveys. Having a network of regional resource laboratories proficient in conducting the folate microbiologic assay and willing and able to perform service work for other countries will be the most efficient way to create an infrastructure wherein qualified laboratories produce reliable blood folate data. Continuous participation of these laboratories in a certification program can verify and document their proficiency. If the resource laboratories conduct the work on a fee-for-service basis, they could become self-sustaining in the long run.
引用
收藏
页码:96 / 108
页数:13
相关论文
共 50 条
  • [1] PISA for low- and middle-income countries
    Bloem, Simone
    COMPARE-A JOURNAL OF COMPARATIVE AND INTERNATIONAL EDUCATION, 2015, 45 (03) : 481 - 486
  • [2] Orthopaedics in low- and middle-income countries
    Andrew Quaile
    International Orthopaedics, 2022, 46 : 1 - 1
  • [3] Hypertension in Low- and Middle-Income Countries
    Schutte, Aletta E.
    Venkateshmurthy, Nikhil Srinivasapura
    Mohan, Sailesh
    Prabhakaran, Dorairaj
    CIRCULATION RESEARCH, 2021, 128 (07) : 808 - 826
  • [4] Orthopaedics in low- and middle-income countries
    Quaile, Andrew
    INTERNATIONAL ORTHOPAEDICS, 2022, 46 (01) : 1 - 1
  • [5] Epilepsy in low- to middle-income countries
    Sen, Arjune
    Newton, Charles R.
    Ngwende, Gift
    CURRENT OPINION IN NEUROLOGY, 2025, 38 (02) : 121 - 127
  • [6] Retinoblastoma in Low- and Middle-Income Countries
    Chintagumpala, Murali
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2019, 36 (02) : 53 - 54
  • [7] A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries
    Babigumira, Joseph B.
    Stergachis, Andy
    Choi, Hye Lyn
    Dodoo, Alexander
    Nwokike, Jude
    Garrison, Louis P., Jr.
    DRUG SAFETY, 2014, 37 (03) : 127 - 134
  • [8] An Emergent Framework of the Market Food Environment in Low- and Middle-Income Countries
    Toure, Djeinam
    Herforth, Anna
    Pelto, Gretel H.
    Neufeld, Lynnette M.
    Mbuya, Mduduzi N. N.
    CURRENT DEVELOPMENTS IN NUTRITION, 2021, 5 (04):
  • [9] A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries
    Joseph B. Babigumira
    Andy Stergachis
    Hye Lyn Choi
    Alexander Dodoo
    Jude Nwokike
    Louis P. Garrison
    Drug Safety, 2014, 37 : 127 - 134
  • [10] Public health oncology: a framework for progress in low- and middle-income countries
    Love, R. R.
    Ginsburg, O. M.
    Coleman, C. N.
    ANNALS OF ONCOLOGY, 2012, 23 (12) : 3040 - 3045